Lake Street analyst Brooks O’Neil raised the firm’s price target on LifeVantage (LFVN) to $30 from $26 and keeps a Buy rating on the shares after the company announced preliminary Q2 results that beat the firm’s forecast and raised FY25 guidance. The firm, which increased its revenue estimates based on the new guidance, believes there is “solid upside to the stock.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFVN:
- Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz
- Morning Movers: AngioDynamics jumps following results and guidance raise
- LifeVantage sees Q2 revenue $67.5M, up 31% vs. last year
- LifeVantage raises FY25 revenue view $235M-$245M from $200M-$210M
- LifeVantage initiated with a Buy at Lake Street